Insulin-like Growth Factor in Breast Cancer Patients Undergoing Chemotherapy
Author Information
Author(s): J-Ph Peyrat, F Revillion, J Bonneterre
Primary Institution: Centre Oscar Lambret
Hypothesis
Does chemotherapy affect plasma IGF-1 concentrations in breast cancer patients?
Conclusion
Chemotherapy does not significantly decrease plasma IGF-1 concentrations in breast cancer patients.
Supporting Evidence
- IGF-1 levels decreased by 10% between the first and second courses of chemotherapy.
- Median IGF-1 level before surgery was significantly higher than during chemotherapy.
- Chemotherapy did not significantly alter IGF-1 levels compared to hormonal treatments.
Takeaway
The study looked at breast cancer patients and found that chemotherapy doesn't lower a certain growth factor in their blood like some other treatments do.
Methodology
Patients received six cycles of adjuvant chemotherapy, and blood samples were collected to measure IGF-1 levels.
Limitations
The study only assessed IGF-1 levels during chemotherapy and did not explore other potential influences on IGF-1 concentrations.
Participant Demographics
Median age of participants was 51 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website